Risk Management for Medical Devices

Navigate the global regulatory landscape for medical devices by mastering FDA classifications and pathways, ISO 13485 and 14971 risk management, and MDR post-market oversight.

Explore ISO 14971 core steps—risk analysis, risk evaluation, risk control, and post-production information—and learn how ISO 13485 and FDA risk-based requirements shape device safety.

The EU MDR 2017 745 classifies devices into risk-based classes: class one, class two, class two B, and class three, driving pre-market scrutiny, post-market oversight, and ongoing safety monitoring.

Implement a cyclic risk management process aligned with ISO 14971 and ISO 13485 to identify hazards, control risk, and monitor effectiveness across the medical device life cycle.

Explore stage one risk analysis in ISO 14971, from input collection and hazard identification to risk estimation and risk analysis reporting, using FMEA, FTA, hazop, and traceability.

Explore the ISO 14971 risk management framework through the risk evaluation and acceptability matrix, mapping probability and severity to green, orange, and red zones, guiding controls, residual risk, and documentation.

Apply stage three risk control under ISO 14971 to reduce unacceptable risks to ALARP levels using a three-tier hierarchy: inherent safety by design, protective measures, and information for safety.

Conduct a formal ISO 14971 risk management review before release to verify plan execution, residual risk acceptability, and ongoing production and post-production monitoring.

This lecture explains risk management with FMEA and fault tree analysis, showing how to identify failure modes, assess effects, calculate RPN using severity, occurrence, detection, and act under ISO 14971.

Bow tie analysis maps hazards, preventive barriers, and recovery controls to show cause, event, and consequence, while Hazop guides a six-step, multidisciplinary risk assessment for medical devices.

Apply Ishikawa fishbone diagram to identify root causes across six Ms: method, material, machine, measurement, manpower, and mother nature, for CAPA and risk control in medical devices per ISO 13485/14971.

Learn how risk management guides the medical device life cycle—from concept and design to post-market surveillance and end of life—using ISO 14971, ISO 13485, and FDA principles.

Integrate risk across the medical device lifecycle by establishing a post production feedback system that collects complaints, user feedback, supplier data, and literature to drive continuous improvement and traceability.

Traceability in ISO 14971 links hazards to residual risk through auditable evidence. The risk management file records verification, controls, and regulatory readiness for post-market surveillance.

Collect post-production evidence from multiple sources to monitor real-world device behavior, update the ISO 14971-based risk management file using an integrated design history platform.

Explore how unvalidated software and material degradation drove major recalls, highlighting hazard analysis, ISO 14971 risk controls, post-market surveillance, and closed loop learning across the product life cycle.

Navigate the evolving digital health risk landscape for medical devices, balancing AI/ML performance, cyber security, human factors, and ethical transparency through ISO 14971 and ISO 24971, with PLC-based risk management.

Explore Canada's booming medical device market, growth drivers like aging population and contract manufacturing, and the regulatory risk management framework—device classifications, ISO 13485/14971, and supply chain dynamics.

Explore Health Canada's risk-based classification of medical devices, from bandages to pacemakers. See Canada's role in global innovation, AI, digital health, telehealth, and regulatory alignment with FDA and MDR.

Explore a structured five-stage risk management loop from hazard identification to monitoring, applying ISO 14971 within the QMS to ensure design controls, traceability, and post-market safety.

Build a living risk management portfolio by applying ISO 14971 across the product life cycle, creating a central risk file, and linking risk to design controls and Capa.

Master risk management for medical devices by identifying hazards, assessing and mitigating risks, documenting evidence, and leveraging modern systems for continuous improvement across the design life cycle to post-market surveillance.